Tech Company Financing Transactions
Checkmate Pharmaceuticals Funding Round
Checkmate Pharmaceuticals closed a $8 million financing round on 8/21/2019. Investors included private investors.
Transaction Overview
Company Name
Announced On
8/21/2019
Transaction Type
Venture Equity
Amount
$7,999,996
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
245 Main St. 2nd Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Checkmate Pharma is developing a new approach for cancer immunotherapy, by specifically activating the immune system to recognize and kill tumor cells throughout the body, without harming normal tissues.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Barry Labinger
Chief Financial Officer
Jon Lieber
Chief Medical Officer
James Wooldridge
Chief Operating Officer
Karen Brennan
Chief Scientific Officer
Art Krieg
VP - Bus. Development
Kleem Chaudhary
VP - General Counsel
Chuck Yon
VP - Operations
Lisa White
VP - Regulatory Affairs
Chris French
VP - Regulatory Affairs
Steven Hamburger
Browse more venture capital transactions:
Prev: 8/21/2019: Brainbase venture capital transaction
Next: 8/21/2019: Podcorn venture capital transaction
Share this article
News on VC Transactions
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs